173 related articles for article (PubMed ID: 38128937)
1. Impact of a pharmacy-led screening and intervention in people at risk of or living with chronic kidney disease in a primary care setting: a cluster randomised trial protocol.
Tesfaye W; Krass I; Sud K; Johnson DW; Van C; Versace VL; McMorrow R; Fethney J; Mullan J; Tran A; Robson B; Vagholkar S; Kairaitis L; Gisev N; Fathima M; Tong V; Coric N; Castelino RL
BMJ Open; 2023 Dec; 13(12):e079110. PubMed ID: 38128937
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Pharmacy Diabetes Screening Trial: protocol for a pragmatic cluster-randomised controlled trial to compare three screening methods for undiagnosed type 2 diabetes in Australian community pharmacy.
Krass I; Carter R; Mitchell B; Mohebbi M; Shih STF; Trinder P; Versace VL; Wilson F; Namara KM
BMJ Open; 2017 Dec; 7(12):e017725. PubMed ID: 29284715
[TBL] [Abstract][Full Text] [Related]
4. Study protocol for The GOAL Trial: comprehensive geriatric assessment for frail older people with chronic kidney disease to increase attainment of patient-identified goals-a cluster randomised controlled trial.
Logan B; Viecelli AK; Johnson DW; Aquino EM; Bailey J; Comans TA; Gray LC; Hawley CM; Hickey LE; Janda M; Jaure A; Jose MD; Kalaw E; Kiriwandeniya C; Matsuyama M; Mihala G; Nguyen KH; Pascoe E; Pole JD; Polkinghorne KR; Pond D; Raj R; Reidlinger DM; Scholes-Robertson N; Varghese J; Wong G; Hubbard RE;
Trials; 2023 May; 24(1):365. PubMed ID: 37254217
[TBL] [Abstract][Full Text] [Related]
5. Bridging the gap between physical and mental illness in community pharmacy (
Wheeler AJ; O'Reilly CL; El-Den S; Byrnes J; Ware RS; McMillan SS
BMJ Open; 2020 Jul; 10(7):e039983. PubMed ID: 32709657
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of a Collaborative Protocolized Approach by Community Pharmacists and General Medical Practitioners for an Australian Minor Ailments Scheme: Protocol for a Cluster Randomized Controlled Trial.
Dineen-Griffin S; Garcia-Cardenas V; Rogers K; Williams K; Benrimoj SI
JMIR Res Protoc; 2019 Aug; 8(8):e13973. PubMed ID: 31400107
[TBL] [Abstract][Full Text] [Related]
7.
Byrne C; Radley A; Inglis SK; Beer LJZ; Palmer N; Pham MD; Healy B; Doyle JS; Donnan P; Dillon JF
BMJ Open; 2020 Aug; 10(8):e036501. PubMed ID: 32868356
[TBL] [Abstract][Full Text] [Related]
8. Expanding community pharmacists' scope of practice in relation to contraceptive counselling and referral: a protocol for a pragmatic, stepped-wedge, cluster randomised trial (ALLIANCE).
Mazza D; Assifi AR; Hussainy SY; Bateson D; Johnston S; Tomnay J; Kasza J; Church J; Grzeskowiak LE; Nissen L; Cameron ST
BMJ Open; 2023 Aug; 13(8):e073154. PubMed ID: 37652588
[TBL] [Abstract][Full Text] [Related]
9. Minimisation of dialysis risk in hospital patients with chronic kidney disease (MinDial): study protocol for a multicentre, stepped-wedge, cluster-randomised controlled trial.
Stelzer D; Binder H; Glattacker M; Graf E; Hahn M; Hollenbeck M; Kaier K; Kowall B; Kuklik N; Metzner G; Mueller N; Seiler L; Stolpe S; Blume C
Trials; 2024 Jun; 25(1):368. PubMed ID: 38849916
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of a chronic kidney disease risk assessment service in community pharmacies.
Gheewala PA; Peterson GM; Zaidi STR; Jose MD; Castelino RL
Nephrology (Carlton); 2019 Mar; 24(3):301-307. PubMed ID: 29493051
[TBL] [Abstract][Full Text] [Related]
11. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
12. Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis.
Black C; Sharma P; Scotland G; McCullough K; McGurn D; Robertson L; Fluck N; MacLeod A; McNamee P; Prescott G; Smith C
Health Technol Assess; 2010 Apr; 14(21):1-184. PubMed ID: 20441712
[TBL] [Abstract][Full Text] [Related]
13. Clinical effectiveness of pharmacy-led versus conventionally delivered antiviral treatment for hepatitis C in patients receiving opioid substitution therapy: a study protocol for a pragmatic cluster randomised trial.
Radley A; de Bruin M; Inglis SK; Donnan PT; Dillon JF
BMJ Open; 2018 Dec; 8(12):e021443. PubMed ID: 30552244
[TBL] [Abstract][Full Text] [Related]
14. Mānuka oil based ECMT-154 versus vehicle control for the topical treatment of eczema: study protocol for a randomised controlled trial in community pharmacies in Aotearoa New Zealand.
Shortt G; Shortt N; Bird G; Kerse K; Lieffering N; Martin A; Eathorne A; Black B; Kim B; Rademaker M; Reiche L; Paa ST; Harding S; Armour M; Semprini A
BMC Complement Med Ther; 2024 Jan; 24(1):61. PubMed ID: 38287323
[TBL] [Abstract][Full Text] [Related]
15. Protocol for a randomised controlled trial evaluating the impact of a community pharmacy discharge medication reconciliation service on unplanned hospital readmissions - The DCMedsRec trial.
Duncan G; Ngo C; Fanning L; Taylor DA; McNamara K; Caliph S; Suen B; Johnston S; Darzins P
Res Social Adm Pharm; 2021 Feb; 17(2):460-465. PubMed ID: 32273252
[TBL] [Abstract][Full Text] [Related]
16. Pharmaceutical care program for patients with chronic kidney disease in the community pharmacy: Detection of nephrotoxic drugs and dose adjustment. Viability study.
Escribá-Martí G; Cámara-Ramos I; Climent-Catalá MT; Escudero-Quesada V; Salar-Ibáñez L
PLoS One; 2022; 17(12):e0278648. PubMed ID: 36548299
[TBL] [Abstract][Full Text] [Related]
17. Implementation of a pragmatic randomized trial of screening for chronic kidney disease to improve care among non-diabetic hypertensive veterans.
Peralta CA; Frigaard M; Rubinsky AD; Rolon L; Lo L; Voora S; Seal K; Tuot D; Chao S; Lui K; Chiao P; Powe N; Shlipak M
BMC Nephrol; 2017 Apr; 18(1):132. PubMed ID: 28399844
[TBL] [Abstract][Full Text] [Related]
18. Electronic Decision Support for Management of CKD in Primary Care: A Pragmatic Randomized Trial.
Peralta CA; Livaudais-Toman J; Stebbins M; Lo L; Robinson A; Pathak S; Scherzer R; Karliner LS
Am J Kidney Dis; 2020 Nov; 76(5):636-644. PubMed ID: 32682696
[TBL] [Abstract][Full Text] [Related]
19. Multicomponent intervention to improve blood pressure management in chronic kidney disease: a protocol for a pragmatic clinical trial.
Kilgallon JL; Gannon M; Burns Z; McMahon G; Dykes P; Linder J; Bates DW; Waikar S; Lipsitz S; Baer HJ; Samal L
BMJ Open; 2021 Dec; 11(12):e054065. PubMed ID: 34937722
[TBL] [Abstract][Full Text] [Related]
20. Community Pharmacist Training-and-Communication Network and Drug-Related Problems in Patients With CKD: A Multicenter, Cluster-Randomized, Controlled Trial.
Lalonde L; Quintana-Bárcena P; Lord A; Bell R; Clément V; Daigneault AM; Legris MÈ; Letendre S; Mouchbahani M; Jouini G; Azar J; Martin É; Berbiche D; Beaulieu S; Beaunoyer S; Bertin É; Bouvrette M; Charbonneau-Séguin N; Desrochers JF; Desforges K; Dumoulin-Charette A; Dupuis S; El Bouchikhi M; Forget R; Guay M; Lemieux JP; Morin-Bélanger C; Noël I; Ricard S; Sauvé P; Ste-Marie Paradis F
Am J Kidney Dis; 2017 Sep; 70(3):386-396. PubMed ID: 28663062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
